[1] Hill CS.Spatial and temporal control of NODAL signaling[J]. Curr Opin Cell Biol, 2018, 51:50-57. [2] Bodenstine TM, Chandler GS, Seftor RE, et al.Plasticity underlies tumor progression:role of Nodal signaling[J]. Cancer Metastasis Rev, 2016, 35(1):21-39. [3] 曾凡才. Nodal及其受体ALK7和ALK4在乳腺癌中的表达功能和临床意义[D]. 成都:电子科技大学, 2014. [4] 曾凡才, 赵太强, 周红. Nodal与肿瘤:表达特征和功能分析[J]. 中国免疫学杂志, 2014, 30(1):133-136. [5] 曾凡才, 何宗洋, 莫冬阳, 等. SB-431542抑制乳腺癌细胞BT-549的增殖和侵袭及其机理研究[J]. 中国细胞生物学学报, 2014, 36(5):602-609. [6] 王轲, 朱敏, 曾凡才, 等. Nodal及其受体在不同发育期小鼠组织器官中的表达[J]. 重庆医学, 2018, 47(12):1575-1579. [7] Strizzi L, Hardy KM, Kirschmann DA, et al.Nodal expression and detection in cancer:experience and challenges[J]. Cancer Res, 2012, 72(8):1915-1920. [8] Morikawa M, Derynck R, Miyazono K. TGF-beta and the TGF-beta family:context-dependent roles in cell and tissue physiology[J]. Cold Spring Harb Perspect Biol, 2016, 8(5), pii: a021873. [9] Piek E, Heldin CH, Ten Dijke P.Specificity, diversity, and regulation in TGF-beta superfamily signaling[J]. FASEB J, 1999, 13(15):2105-2124. [10] 曾凡才, 顾洪, 王轲, 等. 针对ALK4基因的TALEN质粒构建与活性鉴定[J]. 生物技术通报, 2014(5):210-216. [11] Zeng F, Xu G, Zhou T, et al.Reduced expression of activin receptor-like kinase 7 in breast cancer is associated with tumor progression[J]. Med Oncol, 2012, 29(4):2519-2526. [12] Sandomenico A, Ruvo M.Targeting Nodal and Cripto-1:perspectives inside dual potential theranostic cancer biomarkers[J]. Curr Med Chem, 2019, 26:1994-2050. [13] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132. [14] Sampath K, Robertson EJ.Keeping a lid on nodal:transcriptional and translational repression of nodal signalling[J]. Open Biol, 2016, 6(1):150200. [15] Quail DF, Siegers GM, Jewer M, et al.Nodal signalling in embryogenesis and tumourigenesis[J]. Int J Biochem Cell Biol, 2013, 45(4):885-898. [16] Topczewska JM, Postovit LM, Margaryan NV, et al.Embryonic and tumorigenic pathways converge via Nodal signaling:role in melan-oma aggressiveness[J]. Nat Med, 2006, 12(8):925-932. [17] Hsu PD, Lander ES, Zhang F.Development and applications of CRISPR-Cas9 for genome engineering[J]. Cell, 2014, 157(6):1262-1278. [18] Jitariu AA, Cimpean AM, Ribatti D, et al.Triple negative breast cancer the kiss of death[J]. Oncotarget, 2017, 8(28):46652-46662. [19] Scott DF, Postovit LM.Comprehensive characterization of transcript diversity at the human NODAL locus[J]. BioRxiv, 2018. doi:Comprehensive characterization of transcript diversity at the human NODAL locus[J]. BioRxiv, 2018. doi:http://doi.org/10.1101/254409. [20] 曾凡才, 赵太强, 莫冬阳, 等. Nodal基因的剪接异构体分析[J]. 内江师范学院学报, 2014, 29(8):41-47. |